Edesa Biotech Inc (EDSA)

5.18 -0.05  -0.96% NASDAQ Jul 23, 20:00 USD
View Full Chart
Price Chart
View All EDSA News

News

View All Events

Events

Date Type Description
08/12/2021 Earnings Results Q3 2021 Earnings Results
05/14/2021 Earnings Results Q2 2021 Earnings Results
04/22/2021 10:30 EST AGM 2020 Annual General Meeting
02/16/2021 Earnings Results Q1 2021 Earnings Results
12/07/2020 Earnings Results Q4 2020 Earnings Results
08/12/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
  • URL: https://www.edesabiotech.com
  • Investor Relations URL: http://ir.stellarbiotechnologies.com/
  • HQ State/Province: Ontario
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Aug. 12, 2021
  • Last Earnings Release: May. 14, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.